Crohn’s disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
Lin Xiao, Lie Sun, Kang Zhao, Yi-Sheng Pan, Department of General Surgery, Peking University First Hospital, Beijing 100034, China
Author contributions: Xiao L collected patient data and drafting of manuscript; Sun L performed image processing; Zhao K composed manuscript; Pan YS revised and provided recommendation for the manuscript; All authors read and approved the final manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yi-Sheng Pan, MD, Doctor, Department of General Surgery, Peking University First Hospital, No. 8 Xishiku Street, Beijing 100034, China. firstname.lastname@example.org
Received: October 22, 2020
Peer-review started: October 22, 2020
First decision: January 7, 2021
Revised: January 16, 2021
Accepted: March 7, 2021
Article in press: March 7, 2021
Published online: April 15, 2021